Giant Cell Tumors of the Tendon Sheath: Clinical Insights and Surgical Perspectives From Three Cases

  • Hemza Amrane Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2 - Mostefa Ben Boulaid -, 53 Constantine Road, Fesdis 05078, Batna, Algeria.
  • Toufik Boussha Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2, Batna, Algeria
  • Ilies Hasrouri Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2, Batna, Algeria
  • Besma Mekideche Orthopaedic Surgery, Batna Specialist Emergency Hospital, Batna, Algeria
  • Hamid Amrane Ali Nemer Hospital (EPH Merouana Batna), Merouana, Batna, Algeria
  • Nazim Benmayouf Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2, Batna, Algeria
  • Chaouki Derdous Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2, Batna, Algeria
  • Nacer Khernane Benflis Touhami University Hospital (CHU Batna), Faculty of Medicine, University of Batna 2, Batna, Algeria

Sažetak


Giant cell tumours of the tendon sheath (GCTTS) are benign soft tissue tumours that can exhibit locally aggressive behaviour, particularly in the hand and foot. Despite their slow growth, they may cause pain and functional limitations due to compression of adjacent structures. The aim of this study was to describe the clinical presentation, diagnostic process and surgical management of three cases of GCTTS, and to assess postoperative outcomes with a focus on recurrence prevention. Three female patients aged 33, 47 and 62 years presented with progressively enlarging painful swellings in the hand or foot. Each patient underwent a full diagnostic work-up including radiography, ultrasound and magnetic resonance imaging (MRI). Complete surgical excision of the lesions was performed under regional anaesthesia. Histological analysis confirmed the diagnosis of GCTTS in all cases. Patients were followed clinically and radiologically for up to 12 months postoperatively. All patients recovered fully, with resolution of pain, restoration of joint mobility and no motor or sensory deficits. MRI follow-up at 6 and 12 months showed no evidence of tumour recurrence. Histology revealed classic features of GCTTS, including multinucleated giant cells, foamy histiocytes and hemosiderin deposits. No postoperative complications such as infection or hematoma were observed. Functional autonomy was maintained in all cases. GCTTS, while benign, requires meticulous surgical excision to prevent recurrence. Early diagnosis and complete resection result in excellent clinical and functional outcomes. Postoperative surveillance, particularly through MRI, is essential to detect any potential recurrence. Future strategies may include the use of adjuvant therapies in selected high-risk cases to further minimise recurrence risk.

Reference

Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: Radiologic-pathologic correlation. Radiographics. 2008;28(5):1493-518. doi: 10.1148/rg.285085134.

Suresh SS, Zaki H. Giant cell tumor of tendon sheath: case series and review of literature. J Hand Microsurg. 2010 Dec;2(2):67-71. doi: 10.1007/s12593-010-0020-9.

Mastboom MJL, Verspoor FGM, Verschoor AJ, Uittenbogaard D, Nemeth B, Mastboom WJB, et al; TGCT study group. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017 Dec;88(6):688-694. doi: 10.1080/17453674.2017.1361126.

Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, et al. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013 Oct;36(5):505-8. doi: 10.1097/COC.0b013e3182568fb6.

Cavaliere A, Sidoni A, Bucciarelli E. Giant cell tumor of tendon sheath: immunohistochemical study of 20 cases. Tumori. 1997 Sep-Oct;83(5):841-6. doi: 10.1177/030089169708300514.

Briët JP, Becker SJ, Oosterhoff TCh, Ring D. Giant cell tumor of tendon sheath. Arch Bone Jt Surg. 2015 Jan;3(1):19-21. Epub 2015 Jan 15. PMID: 25692164.

Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg Br. 2001 Feb;26(1):72-5. doi: 10.1054/jhsb.2000.0522.

Middleton WD, Patel V, Teefey SA, Boyer MI. Giant cell tumors of the tendon sheath: analysis of sonographic findings. AJR Am J Roentgenol. 2004 Aug;183(2):337-9. doi: 10.2214/ajr.183.2.1830337.

Brahmi M, Vinceneux A, Cassier PA. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. Curr Treat Options Oncol. 2016 Feb;17(2):10. doi: 10.1007/s11864-015-0385-x.

Objavljeno
2025/06/30
Rubrika
Prikaz slučaja